Pain News and Research

Latest Pain News and Research

16 Canadian students living with chronic illness to receive UCBeyond Scholarships

What would you do if you were faced with a chronic illness? Would you walk across Canada to raise awareness for Crohn's disease, build houses in developing countries despite physical pain or dedicate your career to educating young people living with the same disease as you?

6 Oct 2009

Sosei R&D enters agreement with Pharmasol R&D to assign its rights to the assets of AD 923

Sosei Group Corporation, the biopharmaceutical company, today announced that Sosei R&D Ltd., its wholly owned UK subsidiary, has entered into an agreement to assign its rights to the assets of AD 923, an optimised, sublingual formulation of the opioid analgesic fentanyl for the treatment of cancer breakthrough pain, as well as to the device for drug administration to Pharmasol R&D Ltd., a privately held UK company.

6 Oct 2009

AAAHC accreditation for Laser Spine Institute Tampa

Laser Spine Institute, leaders in minimally invasive spinal surgery, is pleased to announce the accreditation of LSI Tampa by the Accreditation Association for Ambulatory Health Care.

6 Oct 2009

FDA accepts ProStrakan's Abstral NDA filing for review

Orexo AB (STO:ORX) today confirms that its partner, ProStrakan Group plc (LSE: PSK), has announced that the New Drug Application (NDA) filing for Abstral has been accepted for review by the US Food and Drug Administration (FDA).

6 Oct 2009

Vivaldi receives US patent for live attenuated influenza vaccines

Vivaldi Biosciences Inc. (Vivaldi), a biotechnology company focused on development of vaccines for influenza, today announced that the United States Patent and Trademark Office has issued US Patent 7,588,768 covering live attenuated influenza vaccines (LAIVs) with modifications to the viral NS1 gene, and methods for producing the vaccines in cell culture systems.

6 Oct 2009

Hypertrophic Cardiomyopathy causes sudden cardiac death in children and young adults

Since Congress declared October “National Sudden Cardiac Arrest Awareness Month” one year ago, more than 250,000 Americans have suffered SCA. For too many, the underlying cause was Hypertrophic Cardiomyopathy (HCM), an inherited disease that affects one out of 500 Americans. What makes it all the more troubling is that early diagnosis of HCM through simple and inexpensive screening can reduce the risk of sudden cardiac death.

6 Oct 2009

Alcohol-impaired drivers account for higher emergency department costs

The costs of drinking and driving are all too apparent, with alcohol involved in 41 percent of all motor vehicle crash fatalities in 2006. In addition to the mortality and morbidity associated with drinking and driving, the economic impact of alcohol impaired driving is considerable, estimated at $51 billion, with medical costs accounting for 15 percent of that figure.

6 Oct 2009

YM BioSciences to acquire Cytopia

Cytopia Limited has today announced that Cytopia and Toronto-based YM BioSciences Inc. ("YM") have signed an exclusive and binding Implementation Agreement ("Agreement") in which it is proposed that YM will acquire all of the issued shares and options in Cytopia.

6 Oct 2009

GE Healthcare announces FDA clearance of CARESCAPE Monitor B850

GE Healthcare today announced the FDA-cleared CARESCAPE™ Monitor B850, which provides caregivers with a unique level of integration between patient monitoring data and hospital information systems. Unlike traditional patient monitors, CARESCAPE Monitor B850 directly links hospital networks, electronic medical records (EMRs), diagnostic images, lab results and third-party devices with real-time patient monitoring data, to support efficient clinical decision-making.

6 Oct 2009

Guided Therapeutics awarded $2.5M NCI grant for marketing LightTouch technology

Guided Therapeutics, Inc. today announced that it was awarded a $2.5 million matching grant by the National Cancer Institute (NCI) to bring to market and expand the array features for its LightTouch™ non-invasive cervical cancer detection technology. The award provides resources to complete the regulatory process and begin manufacturing ramp up for the device and single-patient-use disposable.

6 Oct 2009

ZYNEX obtains accreditation as a Medicare DMEPOS supplier

Zynex, Inc. a provider of pain management systems and electrotherapy products for medical patients with functional disability, announces it has obtained accreditation as a Medicare DMEPOS (Durable Medical Equipment, Prosthetics, Orthotics, and Supplies) supplier, as required to maintain its status as provider to Medicare and several private health insurance companies.

5 Oct 2009

SAGE SOLUTIONS announces market release of Drain Pouch Management Gown

SAGE SOLUTIONS, INC. today announced the market release of its Drain Pouch Management Gown™ (DPM Gown™), a uniquely engineered patient gown, designed to manage drain bulb pouches during post-surgical recovery. The DPM Gown™ features patent pending, two-way pockets that securely hold drain bulbs in place.

5 Oct 2009

Phase 3 clinical study results of Ketotransdel topical cream to be presented

Transdel Pharmaceuticals, Inc. today announced that it will host a conference call and audio webcast on Tuesday, October 6, 2009 at 9:00 am, eastern, to announce the top-line results of its Phase 3 clinical study for Ketotransdel, a topical cream based non-steroidal anti-inflammatory drug ("NSAID") for acute pain.

5 Oct 2009

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Cumberland Pharmaceuticals Inc. announced today that data from two key clinical trials for Caldolor®, an intravenous formulation of ibuprofen approved for treatment of pain and fever in adults, will be presented at the American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting to be held in Phoenix, Ariz., on October 8-11, 2009.

5 Oct 2009

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

Depomed, Inc. today announced top-line results from a Phase 3 clinical trial demonstrating DM-1796 (also referred to as gabapentin ER) achieved a statistically significant reduction in pain associated with postherpetic neuralgia (PHN) versus placebo using the baseline observation carried forward (BOCF) method required by FDA.

5 Oct 2009

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

GlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial evaluating GSK1838262/XP13512 (gabapentin enacarbil) in adult patients with neuropathic pain associated with post-herpetic neuralgia (PHN) who have had a history of inadequate response to gabapentin doses of 1800 mg/day or higher.

5 Oct 2009

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

GVK Biosciences (GVK BIO), Asia’s leading integrated research services provider and Quantitative Solutions (QS), a modeling and simulation (M&S) consultancy to the pharmaceutical and biotech industry, announced a strategic partnership to develop and market clinical trial outcome databases.

5 Oct 2009

Research confirms that probiotic bacteria promotes health and boosts immune system

Functional food is the food industry's fastest-growing product group, its leading products including dairy products which contain probiotics, that is, bacteria promoting health. Valio's Lactobacillus rhamnosus GG (LGG®) is the most frequently studied and used probiotic.

5 Oct 2009

DAS Family Holdings invests in Medical Technologies Unlimited

David Schwedel confirmed that DAS Family Holdings, LP has invested approximately $4 million in Medical Technologies Unlimited, Inc., a developer of advanced medical devices.

5 Oct 2009

Radiofrequency-tonsillotomy: Effective method for treating children with enlarged tonsils

Radiofrequncy-tonsillotomy, which enables surgeons to reduce the size of the tonsillar tissue instead of removing the tonsils entirely, seems to be an effective and safe method of treating children with symptoms of enlarged tonsils.

5 Oct 2009

Pain News and Research

Latest Pain News and Research

16 Canadian students living with chronic illness to receive UCBeyond Scholarships

Sosei R&D enters agreement with Pharmasol R&D to assign its rights to the assets of AD 923

AAAHC accreditation for Laser Spine Institute Tampa

FDA accepts ProStrakan's Abstral NDA filing for review

Vivaldi receives US patent for live attenuated influenza vaccines

Hypertrophic Cardiomyopathy causes sudden cardiac death in children and young adults

Alcohol-impaired drivers account for higher emergency department costs

YM BioSciences to acquire Cytopia

GE Healthcare announces FDA clearance of CARESCAPE Monitor B850

Guided Therapeutics awarded $2.5M NCI grant for marketing LightTouch technology

ZYNEX obtains accreditation as a Medicare DMEPOS supplier

SAGE SOLUTIONS announces market release of Drain Pouch Management Gown

Phase 3 clinical study results of Ketotransdel topical cream to be presented

Cumberland to present clinical trial data of Caldolor at the AAPM annual meeting

Positive results from Depomed's Phase 3 clinical trial of DM-1796 for postherpetic neuralgia

GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgia

GVK Biosciences and Quantitative Solutions to develop and market clinical trial outcome databases

Research confirms that probiotic bacteria promotes health and boosts immune system

DAS Family Holdings invests in Medical Technologies Unlimited

Radiofrequency-tonsillotomy: Effective method for treating children with enlarged tonsils

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Pain News and Research

Latest Pain News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in